The 2026 Nobel Prize in Chemistry goes to Henri B. Kagan and Kenso Soai for discoveries involving mirror-image molecules that have advanced pharmaceutical research and drug manufacturing.
STOCKHOLM: French chemist Henri B. Kagan and Japanese scientist Kenso Soai have won the 2026 Nobel Prize in Chemistry for discoveries that helped scientists control the molecular structures essential to modern medicine.
The Royal Swedish Academy of Sciences announced the winners on October 7, 2026, recognising their pioneering work on nonlinear effects and autocatalysis in asymmetric organic synthesis.
The 2026 Nobel Prize in Chemistry highlights research that has transformed scientists’ understanding of how chemical reactions can produce particular mirror-image molecules, an important process in pharmaceutical development.
Who won the 2026 chemistry Nobel Prize?
Henri B. Kagan, 95, from France, and Kenso Soai, 76, from Japan, will share the prestigious award.
Kagan is recognised for research demonstrating how small differences between molecular forms can be amplified during chemical reactions.
Soai subsequently developed an extraordinary reaction in which a product helps accelerate its own formation, a process known as autocatalysis.
Their combined discoveries addressed a longstanding scientific question about why living organisms favour particular molecular arrangements.
The scientists will share a prize of 12 million Swedish kronor, with the Nobel Prize ceremony scheduled for December 10, 2026.
Why are mirror-image molecules important for medicines?
Many chemical compounds exist in two forms that resemble left and right hands.
Although these molecules contain the same atoms, their different arrangements can produce very different biological effects.
One molecular form of a medicine may deliver the intended treatment, while another may behave differently in the human body.
Controlling which form is produced is therefore important when developing and manufacturing certain pharmaceuticals.
The discoveries recognised by the Nobel committee provide fundamental insights that support more selective chemical reactions and pharmaceutical synthesis.
How did the scientists solve a century-old mystery?
The research focuses on chirality, the scientific term describing molecular handedness.
Living organisms often use one particular mirror-image form of essential biological molecules, a phenomenon known as homochirality.
Kagan demonstrated how a small initial imbalance could produce a much larger preference for one molecular form.
Soai later showed that autocatalytic reactions could amplify such differences dramatically.
Their work helped explain how chemical processes can strongly favour one molecular arrangement over another.
Impact to expect
The discoveries recognised by the 2026 Nobel Prize in Chemistry could continue supporting pharmaceutical innovation by helping researchers design more selective chemical reactions. Their principles are relevant to drug development, chemical manufacturing and scientific investigations into the origins of biological molecules, although individual medicines still require extensive safety testing.
The award celebrates decades of research that connected fundamental chemistry with practical applications, demonstrating how understanding molecules can contribute to the development of modern medicines.
